TrialHuman psychopharmacology2022

A phase 1 double-blind, placebo-controlled study of zuranolone (SAGE-217) in a phase advance model of insomnia in healthy adults.

Amy Bullock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.